NewsBenzinga팔벨라 테라퓨틱스, 미세낭성 림프관 기형 치료를 위한 3상 SELVA 임상시험 및 진행 중인 공개 연장 연구에 대해 FDA 희귀의약품 개발 사무소로부터 3년차 보조금 지원 받다 팔벨라 테라퓨틱스, 미세낭성 림프관 기형 치료를 위한 3상 SELVA 임상시험 및 진행 중인 공개 연장 연구에 대해 FDA 희귀의약품 개발 사무소로부터 3년차 보조금 지원 받다 Benzinga 2026.09.28 11:35 (GMT+0) Open on Benzinga Other news Nvidia Director Reportedly Warns of ‘Irreplaceable Talent’ Loss: Board Urged to Bring Back Jensen Huang as NVDA Stock Slips Anthony Scaramucci Says Trump Could Abandon Republicans After Midterm Losses to Focus on 'Money' With Jared Kushner Cloudastructure (CSAI) Shares Jump 52% After-Hours: What Investors Should Know Trump Administration ‘Monitoring’ All Threats As Iran Reportedly Explores Dirty Bomb, Chemical Weapons Attack on US: Report Elon Musk’s Cybercab Ambitions Get a $3.3 Billion Boost — Tesla Plans 1 Million Units a Year at Berlin Factory Former Robinhood Software Engineer Admits Using Confidential Information to Trade Crypto Perpetuals, Agrees to Forfeit Proceeds
Nvidia Director Reportedly Warns of ‘Irreplaceable Talent’ Loss: Board Urged to Bring Back Jensen Huang as NVDA Stock Slips
Anthony Scaramucci Says Trump Could Abandon Republicans After Midterm Losses to Focus on 'Money' With Jared Kushner
Trump Administration ‘Monitoring’ All Threats As Iran Reportedly Explores Dirty Bomb, Chemical Weapons Attack on US: Report
Elon Musk’s Cybercab Ambitions Get a $3.3 Billion Boost — Tesla Plans 1 Million Units a Year at Berlin Factory
Former Robinhood Software Engineer Admits Using Confidential Information to Trade Crypto Perpetuals, Agrees to Forfeit Proceeds